London’s AIM All Share has managed to post some steady gains during Thursday’s session, although the gains of less than three points meant the index was significantly lagging the main board, closing at 717.31.
- Fiinu +158%
- Celadon +100%
- Cambridge Nutritional Sciences +36%
- Deltex Medical -50%
- Proton Motors -27%
Fiinu LON:BANK was topping the board again on Thursday, advancing a further 158% as the company continued to find cheer off the back of yesterday’s announcement regarding a white label agreement. On Tuesday night the stock was trading at .7p so today’s closing print of 6.95p is notable, but as we noted this deal still has an element of risk.
Celadon LON:CEL was in second place, up 100% after the pharmaceuticals firm announced an update on its strategic collaboration with Valeos Pharma. The deal is now close to delivering tangible results and first invoices are now being run. Management see this as being a pivotal moment for the business.
Cambridge Nutritional Sciences [LON:CNSL] gets the notable mention, up 36% following news it had settled a claim with the DHSC. Both parties have agreed to walk away, picking up their own legal costs. The removal of this distraction was sufficient to fuel buying into the stock.
Deltex Medical LON:DEMG was 50% down on the day. This morning the business issued a year end trading update and advised that it intends to cancel its listing. Revenues were up 17% but cash on hand was eroded so as part of a bid to reduce the cost base, the cancellation has been proposed. The CEO is also set to stand down.
Proton Motors LON:PPS was 27% lower but there’s no news here. The company is also seeking a delisting although this process starts a couple of weeks back. The spread is wide and volumes were thin, so arguably nothing to see here.
